Literature DB >> 1931477

The disposition of bupivacaine following a 72 h interpleural infusion in cholecystectomy patients.

H Kastrissios1, E J Triggs, G A Mogg, J W Higbie.   

Abstract

The disposition of bupivacaine and degree of analgesia following a 72 h interpleural infusion was investigated in 12 adult patients undergoing elective cholecystectomy. The infusion regimen of an initial interpleural bolus dose of 20 ml of 0.5% bupivacaine HCl with adrenaline (1:200,000) followed by continuous infusion at a rate of 8 ml h-1 of 0.25% plain bupivacaine HCl was designed to achieve continuous post-operative pain relief for 72 h. In practice an additional bolus dose (identical to the first) administered 5 h after infusion commencement was required to achieve adequate pain relief on the first postoperative day. The mean measured steady-state plasma bupivacaine concentration was 2.1 mg l-1 (s.d. +/- 0.54, range 1.3-3.2 mg l-1). Disposition parameters for bupivacaine measured for the infusion were calculated by non-compartmental methods and compared with previous values obtained after single and multiple interpleural bolus dose administration. No statistically significant differences were noted and, in particular, the systemic clearance of bupivacaine (mean 10.2 l h-1 s.d +/- 3.0; range 6.3-16.0 1 h-1) remained unchanged following the long-term interpleural infusion. Analgesia was deemed satisfactory throughout the entire post-operative period.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1931477      PMCID: PMC1368454          DOI: 10.1111/j.1365-2125.1991.tb03892.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Intrapleural administration of 0.25%, 0.375%, and 0.5% bupivacaine with epinephrine after cholecystectomy.

Authors:  K E Strömskag; F Reiestad; E L Holmqvist; S Ogenstad
Journal:  Anesth Analg       Date:  1988-05       Impact factor: 5.108

2.  Pharmacokinetics of interpleural bupivacaine in patients undergoing cholecystectomy.

Authors:  G A Mogg; E J Triggs; Z Ismail; J Higbie; M Frost
Journal:  Br J Anaesth       Date:  1990-06       Impact factor: 9.166

3.  Intrapleural bupivacaine--a kinetic and dynamic evaluation.

Authors:  J L Seltzer; G E Larijani; M E Goldberg; A T Marr
Journal:  Anesthesiology       Date:  1987-11       Impact factor: 7.892

4.  The effect of local anaesthetics on the central circulation and respiration in man and dog.

Authors:  L Jorfeldt; B Löfström; B Pernow; B Persson; J Wahren; B Widman
Journal:  Acta Anaesthesiol Scand       Date:  1968       Impact factor: 2.105

Review 5.  Pharmacokinetics of local anaesthetics.

Authors:  G T Tucker
Journal:  Br J Anaesth       Date:  1986-07       Impact factor: 9.166

6.  Determination of bupivacaine in human plasma by high-performance liquid chromatography.

Authors:  U W Wiegand; R C Chou; E Lanz; E Jähnchen
Journal:  J Chromatogr       Date:  1984-11-09

7.  Some considerations on the estimation of steady state apparent volume of distribution and the relationships between volume terms.

Authors:  P S Collier
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

8.  Continuous perineural infusion of bupivacaine for prolonged analgesia: pharmacokinetic considerations.

Authors:  D D Denson; P P Raj; F Saldahna; R A Finnsson; W A Ritschel; T H Joyce; J L Turner
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1983-12

9.  The kinetics of bupivacaine (Carbostesin) plasma concentrations during epidural anesthesia following intraoperative bolus injection and subsequent continuous infusion.

Authors:  O Richter; K Klein; J Abel; F K Ohnesorge; H J Wüst; F M Thiessen
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1984-11

10.  Plasma bupivacaine concentrations during postoperative continuous epidural analgesia.

Authors:  S A Schweitzer; D J Morgan
Journal:  Anaesth Intensive Care       Date:  1987-11       Impact factor: 1.669

View more
  1 in total

Review 1.  Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions.

Authors:  J M Thomas; S A Schug
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.